MedPath
HSA Approval

NEO-BETASONE CREAM

SIN04129P

NEO-BETASONE CREAM

NEO-BETASONE CREAM

March 28, 1990

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07CC01

betamethasone and antibiotics

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

NEOMYCIN SULPHATE EQV NEOMYCIN

0.5% w/w

Neomycin

BETAMETHASONE (as 17-VALERATE)

0.1% w/w

Betamethasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEO-BETASONE CREAM - HSA Approval | MedPath